# Antibiotics: summary tables

## Table 9.3 Penicillins

| Antibiotic | Indications | Considerations |
|------------|-------------|----------------|
| Penicillin G (benzylpenicillin, 'penicillin') | Gram +ve: streptococci (chest, throat, endocarditis, cellulitis), meningococcus, diphtheria, anthrax, leptospirosis, Lyme disease. | Give IV, poor oral absorption. Dose adjust for GFR. SE: allergy, rash, N&V, C. difficile, cholestasis. |
| Penicillin V (phenoxymethylpenicillin) | Prophylaxis: splenectomy/hypo-splenism, rheumatic heart disease. | Oral bioavailability may vary. |
| Ampicillin/amoxicillin | Amino acid side chain extends penicillin spectrum to include enterobacteria (but ↓ activity against Gram +ve): URTI, sinusitis, chest, otitis media, UTI, H. pylori. | Ampicillin IV, amoxicillin PO. Dose adjust for GFR. SE: as per penicillin G, rash with EBV. |
| Amoxicillin+clavulanic acid (co-amoxiclav) | Used if resistance to narrower-spectrum antibiotics: chest, pyelonephritis, cellulitis, bone. | Dose adjust for GFR. SE: as per amoxicillin. |
| Piperacillin+tazobactam | Broad spectrum including Gram +ve, Gram -ve, Pseudomonas: neutropenic sepsis, hospital-acquired/complicated infection. | Tazobactam has ↑penetration of blood-brain barrier. Dose adjust for GFR. SE: as per penicillin G. Myelosuppression with prolonged use (rare). |
| Flucloxacillin | β-lactamase resistant, Staphylococcus: skin, bone, post-viral pneumonia. | Dose adjust for GFR. SE: allergy, rash, N&V, cholestasis. |

## Table 9.4 Cephalosporins

| Antibiotic | Indications | Considerations |
|------------|-------------|----------------|
| Cefalexin (1st generation) | Gram +ve infection: UTI, pneumonia. | ↓First-line use in UK due to risk of C. difficile. Caution: false +ve urinary glucose and Coomb's test. SE: allergy, rash, N&V, cholestasis. Ceftriaxone can precipitate in urinary tract and biliary tree = pseudolithiasis. |
| Cefuroxime (2nd generation) | Gram +ve and Gram -ve (Enterobacteriaceae, H. influenzae): UTI, sinusitis, skin, wound. |
| Cefotaxime (3rd generation) | Broad spectrum (not Pseudomonas, Enterococcus spp, Bacteroides). |
| Ceftriaxone (3rd generation) | Meningococcus. Broad spectrum (not Pseudomonas, Enterococcus spp, Bacteroides). |
| Ceftazidime (3rd generation) | Broad spectrum including Pseudomonas but ↓activity against Gram +ve: empirical treatment of neutropenic sepsis. |

## Table 9.5 Carbapenems

| Antibiotic | Indications | Considerations |
|------------|-------------|----------------|
| Imipenem Meropenem Ertapenem | Broad spectrum (Gram +ve, Gram -ve, aerobes, anaerobes): hospital-acquired/ventilator-associated/ complicated infection, neutropenic sepsis. | Dose adjust for GFR. Imipenem given with cilastatin to ↑renal metabolism. SE: N&V, C. difficile, rash, eosinophilia, ↑plts, ↑LFTs, seizures. |

## Table 9.6 Lipopeptides and polymyxins

| Antibiotic | Indication | Considerations |
|------------|------------|----------------|
| Lipopeptides |
| Vancomycin Teicoplanin | Complicated Gram +ve including MRSA. Oral for C. difficile (not absorbed). | Dose IV to trough serum concentration. SEs: nephrotoxic (monitor creatinine, care with other nephrotoxics) ototoxic, ↓plts. |
| Polymyxins |
| Colistin, polymyxin B | Multi-resistant Gram -ve. | Nephrotoxicity in ~50%. Inhaled colistin for ventilator-associated pneumonia. |